14-88011233-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000267549.5(GPR65):āc.386G>Cā(p.Arg129Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000186 in 1,613,938 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000267549.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR65 | NM_003608.4 | c.386G>C | p.Arg129Thr | missense_variant | 2/2 | ENST00000267549.5 | NP_003599.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR65 | ENST00000267549.5 | c.386G>C | p.Arg129Thr | missense_variant | 2/2 | 1 | NM_003608.4 | ENSP00000267549 | P1 | |
ENST00000554433.1 | n.96-14C>G | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000997 AC: 25AN: 250876Hom.: 0 AF XY: 0.0000885 AC XY: 12AN XY: 135564
GnomAD4 exome AF: 0.000185 AC: 271AN: 1461658Hom.: 1 Cov.: 33 AF XY: 0.000182 AC XY: 132AN XY: 727142
GnomAD4 genome AF: 0.000190 AC: 29AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.386G>C (p.R129T) alteration is located in exon 2 (coding exon 1) of the GPR65 gene. This alteration results from a G to C substitution at nucleotide position 386, causing the arginine (R) at amino acid position 129 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at